营养不良对药物药代动力学影响的临床视角
本文综述营养不良对药物吸收、分布、代谢和排泄的影响,重点关注儿童、孕妇、老年人及中低收入国家人群等脆弱群体。营养不良通过改变体成分、器官功能和血浆蛋白水平影响药代动力学,尤其对高蛋白结合率酸性药物和治疗窗狭窄药物风险更高。文章强调需制定个体化给药方案并呼吁更多研究以指导临床指南。
要点
- 营养不良可改变药物吸收、分布、代谢和排泄,脆弱人群风险更高。
- 低白蛋白血症可能增加高蛋白结合率酸性药物的游离分数,潜在升高毒性风险。
- 营养不良对肝酶和肾功能的影响可导致药物清除不可预测,尤其对窄治疗窗药物。
核心结论
- 营养不良显著改变药物药代动力学,需针对脆弱人群制定个体化给药方案。
研究设计与样本
- 本文为综述,聚焦营养不良对药代动力学的临床影响及脆弱人群。
主要发现
- 营养不良与体成分、器官功能及血浆蛋白水平改变相关,可影响药物吸收、分布、代谢和排泄。
- 低血清白蛋白可能增加高蛋白结合率酸性药物的游离分数,潜在升高毒性风险,但关系并非普遍直接。
- 营养不良对细胞色素P450同工酶等肝酶及肾功能的影响可导致药物清除不可预测,尤其对窄治疗窗药物。
- 新证据提示营养不良与药物基因组学存在交互作用,遗传变异可进一步调节药物代谢和反应。
临床怎么用
- 对营养不良患者应开发量身定制的给药方案和适应性治疗策略以优化治疗结局。
局限性
- 需要更多稳健研究以指导临床指南并改善全球营养不良人群的健康公平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Malnutrition significantly alters the pharmacokinetics of medications, particularly in vulnerable populations such as children, pregnant women, elderly individuals, and individuals in low- and middle-income countries. These populations are often more vulnerable to the effects of malnutrition because of physiological, metabolic and socioeconomic factors. Changes in body composition, organ function and plasma protein levels associated with malnutrition can impact drug absorption, distribution, metabolism and excretion. In malnourished individuals, decreased serum albumin levels may increase the free (unbound) fraction of highly protein-bound acidic drugs, potentially elevating the risk of toxicity. However, this relationship is not universally straightforward, as it depends on the drug's protein-binding characteristics, hepatic and renal function, volume of distribution and compensatory changes in drug clearance. In addition, malnutrition's effects on liver enzymes, such as cytochrome P450 isoforms, and kidney function can result in unpredictable drug clearance, particularly for narrow-therapeutic-index medications. Emerging evidence also highlights the interplay between malnutrition and pharmacogenomics, with genetic variations further modulating drug metabolism and response. Addressing these complexities requires the development of tailored dosing regimens and adaptive therapeutic strategies to optimise treatment outcomes in these at-risk groups. This review accentuates the critical need for more robust research to inform clinical guidelines and improve health equity in managing malnourished populations globally.
引用
- Ngcobo NN. Malnutrition and Its Effect on Drug Pharmacokinetics: A Clinical Perspective. Clin Pharmacokinet. 2025. PMID: 40797120. doi:10.1007/s40262-025-01558-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。